provides a new combination of value-added skills with science know-how that aids in the evaluation of new targets and launches new drugs. They represent a new generation of companies with a broad and customizable set of basic, translational and clinical research capabilities that serve as an extension of your in-house operations. They help you identify companion tests.Their responsiveness and personalized services in soluble and cell-based assay development, biomarker testing, clinical trial substudies and central lab support, including biostorage exceed the industry standard. They are GLP and GCLP compliant and a CLIA approved laboratory. They adhere to ISBER best practices for repositories of biological materials for research and are a 21 CFR Part 11 compliant biospecimen management system.